Vertebrate tissues use multiple junctional types to establish and maintain tissue architecture, including gap junctions for cytoplasmic connectivity and tight junctions (TJs) for paracellular and/or cell polarity barriers. The integral membrane proteins of gap junctions are connexins, whereas TJs are a complex between occludin and members of a recently characterized multigene family, the claudins. In normal brain, astrocytes are coupled by gap junctions composed primarily of connexin43 (Cx43), whereas TJs have not been detected in these cells. We now show that treatment of primary human astrocytes with the cytokine interleukin-1␤ (IL-1␤) causes rapid induction of claudin-1, with an expression pattern reciprocal to loss of Cx43. Treatment also led to protracted downregulation of occludin but no change in expression of zonula occludens proteins ZO-1 and -2. Immunofluorescence staining localized claudin-1 to cell membranes in IL-1␤-treated astrocytes, whereas freezefracture replicas showed strand-like arrays of intramembranous particles in treated cells resembling rudimentary TJ assemblies. We conclude that in human astrocytes, IL-1␤ regulates expression of the claudin multigene family and that gap and tight junction proteins are inversely regulated by this proinflammatory cytokine. We suggest that in pathological conditions of the human CNS, elevated IL-1␤ expression fundamentally alters astrocyte-to-astrocyte connectivity.
Vertebrate tissues use multiple junctional types to establish and maintain tissue architecture, including gap junctions for cytoplasmic connectivity and tight junctions (TJs) for paracellular and/or cell polarity barriers. The integral membrane proteins of gap junctions are connexins, whereas TJs are a complex between occludin and members of a recently characterized multigene family, the claudins. In normal brain, astrocytes are coupled by gap junctions composed primarily of connexin43 (Cx43), whereas TJs have not been detected in these cells. We now show that treatment of primary human astrocytes with the cytokine interleukin-1␤ (IL-1␤) causes rapid induction of claudin-1, with an expression pattern reciprocal to loss of Cx43. Treatment also led to protracted downregulation of occludin but no change in expression of zonula occludens proteins ZO-1 and -2. Immunofluorescence staining localized claudin-1 to cell membranes in IL-1␤-treated astrocytes, whereas freezefracture replicas showed strand-like arrays of intramembranous particles in treated cells resembling rudimentary TJ assemblies. We conclude that in human astrocytes, IL-1␤ regulates expression of the claudin multigene family and that gap and tight junction proteins are inversely regulated by this proinflammatory cytokine. We suggest that in pathological conditions of the human CNS, elevated IL-1␤ expression fundamentally alters astrocyte-to-astrocyte connectivity.
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The cytokine interleukin-1␤ (IL-1␤) is found at low levels in the CNS, where its expression is restricted to specific neuronal tracts (Breder et al., 1988) . However, levels of IL-1␤ increase dramatically in a number of different inflammatory and degenerative conditions, with expression localized to activated microglia and macrophages. Experiments both in vivo and in vitro have strongly implicated a role for this cytokine in pathogenesis of CNS disease (for review, see Rothwell et al., 1997) . IL-1␤ is a key activator for human astrocytes in vitro (Lee et al., 1993) and has been implicated in the induction of reactive astrogliosis, a common response to brain injury (Giulian et al., 1988) . Studies using in vivo models have suggested that reactive astrogliosis is associated with the development of a CNS environment less permissive for the movements of solutes (Nicholson and Sykova, 1998) , but the mechanisms underlying this are unknown. One possibility is that changes in astrocyte-to-astrocyte connectivity play a role in this response.
In the CNS, distinct specialized junctional complexes mediate cell-cell connectivity. Intercellular communication is mediated by gap junctions, which allow the direct exchange of small molecules between cells . Gap junctions may also form a macromolecular signaling complex, or nexus, at appositional membranes via interaction of the cytoplasmic domain with the scaffolding protein zonula occludens-1 (ZO-1) (Giepmans and Moolenaar, 1998; Toyofuku et al., 1998) . In contrast, tight junctions (TJs) are complexes of proteins that mediate paracellular sealing, thereby restricting diffusion of fluid and small molecules in the extracellular space ("barrier function") and also function to establish and maintain cell polarity ("fence function") . Although the first intramembrane TJ-associated protein identified was the 65 kDa protein occludin (Furuse et al., 1993) , recent studies have also strongly supported a role for members of a novel family of integral membrane proteins, the claudins (Furuse et al., 1998a,b) such that TJ formation is now thought to involve an interaction between occludin and one or more of the claudins. The carboxyl terminus of claudin, in turn, associates with the second PDZ domain of ZO-1, linking the complex to a cellular scaffold .
In the normal CNS, gap junctions composed primarily of connexin43 (Cx43), with a minor contribution by other connexins such as Cx30, Cx40, Cx45, and Cx46 (Dermietzel, 1996; Spray et al., 1998) , abundantly interconnect human cortical astrocytes, linking these cells into a functional syncytium. In contrast, TJs have not been noted among these cells (Massa and Mugnaini, 1985; Rash et al., 1996) . However, we now show that IL-1␤ causes a rapid and robust induction of the TJ-associated protein, claudin-1 (Cln-1) with a temporal pattern reciprocal to the previously reported IL-1␤-induced loss of Cx43 in the same cells (John et al., 1999) . Striking morphological changes at the cell membrane accompanied this response. Thus, a switch from gap junction to TJ-associated proteins and morphology occurs under conditions in which IL-1␤ is elevated, which may alter intercellular and extracellular diffusion and thereby contribute to the dysfunctional state associated with inflammatory or degenerative conditions of the CNS.
MATERIALS AND METHODS
Astroc yte cultures and c ytok ines. Human fetal cortical astrocyte cultures were established, and purity (Ͼ98%) was determined as described previously (Lee et al., 1992) . Tissue collection was approved by the Albert Einstein College of Medicine Institutional C linical Review Committee (CCI number 94 -32). Recombinant human IL -1␤ was a gift from National C ancer Institute Biological Response Modifiers Program (Bethesda, MD). Recombinant human IL -1Ra, the endogenous IL -1␤ receptor antagonist, was from R & D Systems (Minneapolis, M N) .
Immunostaining. For primary antibodies (except occludin), cells were fixed 5 min in 1% paraformaldehyde, rinsed, then blocked 30 min with PBS ϩ 10% normal goat serum ϩ 0.4% Triton X-100. For occludin, cells were fixed in 2% paraformaldehyde incubated in ethanol and acetic acid (95:5 v:v) 20 min at Ϫ20°C and blocked with 10% goat serum in PBS 30 min at RT. C ells were stained overnight at 4°C with primary antibodies against junctional proteins (C ln-1, Z O-1, Z O-2, Z O-3, and occludin; Zymed, South San Francisco, CA; C x43 and Z O-3, Chemicon, Temecula, CA) diluted 1:1000 in blocking solution (see above). After rinsing in PBS with 0.4% Triton X-100 (except for occludin staining, in which no Triton was used), cells were incubated 1 hr at RT with secondary antibodies conjugated to Alexa 488 or 546 (Molecular Probes, Eugene, OR), examined on a Nikon Eclipse TE300 microscope and photographed using a SPOT-RT digital camera (Diagnostic Imaging) with phase-contrast and epifluorescence optics.
SDS-PAGE and immunoblotting. Confluent astrocyte cultures (treated as described in Results) were lysed in boiling 1ϫ SDS-PAGE loading buffer to obtain whole-cell extracts, which were then centrif uged, and pellets were discarded. For cell membrane extracts, astrocytes were lysed in 10 mM Tris-HC l buffer (4°C, pH 7.5), centrif uged, and pellets were resuspended in boiling 2ϫ SDS-PAGE loading buffer. Proteins were separated using SDS-PAGE and transferred onto poly vinylidene difluoride membrane as described (John et al., 1999) . Parallel blots were probed with polyclonal antisera for C ln-1, occludin, Z O-1, Z O-2, or Z O-3, or with monoclonal anti-C x43 or anti-Z O-3.
RT-PCR for human Cln-1. Total RNA was isolated from confluent control or IL -1␤-treated cultures and subjected to RT-PCR as previously described (John et al., 1999) . Primers were based on reported sequence of human C ln-1: forward, 5Ј-AAC GCG GGG C TG CAG C TG TTG-3Ј; and reverse, 5Ј-GGA TAG GGC C TT GGT GTT GGG T-3Ј (GenBank accession numbers AF115546, AF134160, and AF101051). Human ␤-actin primers were obtained commercially (C lontech, Palo Alto, CA). Conditions applied for PCR were: 95°for 5 min, 31 cycles of 95°C for 1 min, 71.5°C for 1 min, 72°C for 1 min, and 72°C for 7 min. Samples were separated by electrophoresis in ethidium bromide-impregnated 1.6% agarose gels. PCR product was identified by cloning and sequencing of five independent clones using methods previously reported (John et al., 1999) .
T hin section electron microscopy. Human astrocyte monolayers cultured in 5% fetal calf serum were treated with 0 or 10 ng /ml IL -1␤ for 24 hr. C ells were fixed 1 hr at RT in 2.5% glutaraldehyde, 0.1 M cacodylate, and 0.1% tannic acid, post-fixed in osmium tetroxide, dehydrated stepwise in graded alcohols to 100%, and embedded in Epon. Ultrathin sections counterstained with lead citrate and uranyl acetate were then examined on a JEOL 100C X transmission electron microscope.
Freeze-f racture electron microscopy. Human astrocytes grown on 100 mm dishes were treated with 10 ng /ml IL -1␤ for 0 or 24 hr, fixed in 2.5% glutaraldehyde in 0.1% cacodylate buffer 60 min at RT, and rinsed in 0.1% cacodylate buffer (3ϫ for 10 min). C ells were brought stepwise to 20% glycerol in 0.1% cacodylate buffer, rapidly frozen by immersion in ultracold Freon-22, and fractured in a Cressington CF E-50 Freeze Etch unit. Samples were platinum shadowed at a 45°angle, rotary shadowed with carbon, and examined on a JEOL 100C X transmission electron microscope, and stereo pairs were taken at 8°angles.
RESULTS

Immunolocalization of Cln-1 to cell membranes in IL-1␤ treated astrocyte cultures
Localization of Cx43, Cln-1, occludin, and ZO-1, -2, and -3 were examined in control and IL-1␤-treated primary human astrocyte cultures using immunofluorescence staining. In control cultures there was robust expression of Cx43, particularly at cell membranes in which punctate staining was observed at sites of cellcell contact (Fig. 1 A) . Conversely, in the same cultures Cln-1 staining was totally absent (Fig. 1C) . After treatment of cultures with 10 ng/ml IL-1␤ for 24 hr, Cx43 was lost (Fig. 1 B) , which contrasted with the robust expression of Cln-1, particularly at cell membranes (Fig. 1 D) . The striking change from Cx43 to Cln-1 expression after 24 hr of 10 ng/ml IL-1␤ treatment was particularly evident when images obtained from double-labeled cells were superimposed (Fig. 1 E,F ) .
Expression of occludin and ZO-1 and -2 was also observed at cell membranes in control cultures, and no substantive change was seen in their localization after 10 ng/ml IL-1␤ treatment, although over a period of ϳ30 -55 hr of treatment the number of cells with occludin localized to cell membranes gradually decreased. In cells that maintained occludin expression, no change in intensity or membrane localization was seen (data not shown). Examination of the phase image shows that the punctate staining is localized to cell-cell contacts in control cells ( G). IL-1␤ treatment caused a complete loss of Cx43 ( B). Double labeling of cells for Cln-1 ( green) showed no staining in control cells ( C), whereas treatment with IL-1␤ caused Cln-1 staining to be evident at cell membranes of treated astrocytes ( D), although the phase image ( H ) shows that Cln-1 is not uniquely localized to sites of cell-cell contact. Note the striking change in cell morphology from flat to stellate, which is a characteristic effect of treatment with IL-1␤. Overlay of the red and green channels is shown in control ( E) and IL-1␤-treated cells ( F ). Scale bar, 25 m.
Expression of ZO-3 was not detected in either control or cytokine-treated cultures using two commercially available antibodies (data not shown).
IL-1␤ treatment of primary human astrocytes causes rapid and robust induction of Cln-1
The patterns of expression of Cx43, Cln-1, occludin and ZO-1, -2, and -3 were examined in control and IL-1␤-treated primary human astrocyte cultures using immunoblotting of whole-cell extracts (Fig. 2 A) . No signal for Cln-1 was detected in control cultures; however, robust expression of a single 22 kDa band corresponding to Cln-1 was observed within 6 hr after addition of IL-1␤ (10 ng/ml) to cultures, reaching a plateau at 15 hr after treatment. The expression pattern of Cln-1 was reciprocal to the dramatic downregulation of Cx43 that was observed within 6 hr after treatment with IL-1␤, and Cx43 was not detected by immunoblotting from 15 hr onward, in agreement with previous findings (John et al., 1999) . After IL-1␤ treatment there was progressive downregulation of occludin over a more protracted time course (Fig. 2 A) . Expression of both ZO-1 and ZO-2 was detected in control cultures and did not alter after IL-1␤ treatment, but as with the immunolocalization studies, no expression of ZO-3 was detected (negative data not shown).
Immunoblotting of whole-cell extracts versus cell membrane fractions from control and IL-1␤-treated cultures was used to determine whether Cln-1 expressed after IL-1␤ treatment was associated with cell membranes. As a control, these blots were also probed for Cx43. In agreement with previous work from our laboratories, levels of the 46 and 44 kDa (P2 and P1) isoforms of Cx43 were enriched in membrane fraction compared with wholecell extract, in which the 42 kDa, or NP, isoform of Cx43 predominated (Fig. 2 B) . Neither membrane fraction nor whole-cell extract contained detectable Cx43 signal at 16 and 24 hr after treatment of cultures with IL-1␤. In contrast, whereas no signal for Cln-1 was detectable by immunoblotting either in whole-cell extracts or membrane fractions from control cultures, strong Cln-1 expression was observed at both 16 and 24 hr after IL-1␤ treatment, and the signal was enriched in the membrane fractions.
Immunoblots of whole-cell extracts from astrocyte cultures demonstrated that the effect of IL-1␤ on Cx43 and Cln-1 expression was concentration-dependent and could be detected at doses as low as 10 -100 pg/ml (Fig. 2C) . In addition, the effects of the highest concentrations of IL-1␤ (10 ng/ml) were significantly inhibited by cotreatment with the naturally occurring selective IL-1 receptor antagonist (IL-1Ra, 500 ng/ml; Fig. 2C ).
Induction of Cln-1 mRNA after IL-1␤ treatment of human astrocytes
RT-PCR using specific primers demonstrated induction of Cln-1 mRNA in human astrocyte cultures after 16 hr treatment with IL-1␤ (Fig. 2 D) . To confirm the identity of the PCR product, bands were excised from the gel, cloned, and sequenced. Data obtained from five clones gave sequences Ͼ97% identical to GenBank sequence of Cln-1/SEMP-1 cloned from Caco-2 and mammary epithelial cells (GenBank accession numbers AF115546, AF134160, and AF101051). No band was detected in PCR samples in the absence of reverse transcriptase. This induction of Cln-1 mRNA is directly reciprocal to our previously reported loss of Cx43 (John et al., 1999) .
Freeze-fracture and thin-section electron microscopy
Control and IL-1␤-treated cell membranes were examined using both transmission (TEM) and freeze-fracture (FF) electron microscopy. Membranes were well preserved, and on FF images multiple square arrays (Fig. 3A,C) , a classic identifying marker for astrocytes (Massa and Mugnaini, 1985; Rash et al., 1996) , were seen in both control and treated cells. Examination of both FF and TEM images showed a marked difference in the morphology of cell membranes between control and IL-1␤-treated cells. In control cells, FF images showed multiple E-and P-face gap junctional plaques of varying sizes (Fig. 3A) . Gap junctions were also found between astrocytes using TEM (Fig. 3B) . In contrast, examination of cell membranes after treatment of cells with IL-1␤ showed no gap junctions, suggesting loss of all gap junction proteins. Instead, FF images of membranes of IL-1␤-treated cells showed the presence of strand-like arrays of ϳ10 nm particles at multiple sites on P-face membranes (Fig. 3C ). While these strands were clearly not classical TJs, their morphology was reminiscent of rudimentary tight junction strands. In agreement with these findings, multiple sites of close membrane apposition were observed in IL-1␤-treated astrocytes using TEM, which again did not resemble classical TJs (Fig. 3D) . These ultrastructural data indicate that treatment with IL-1␤ induces morphological changes in primary human astrocyte junctional membranes that parallel the switch from expression of Cx43 to Cln-1 in these cells.
DISCUSSION
This study demonstrates that treatment of primary human astrocytes with the proinflammatory cytokine IL-1␤ results in the specific induction of an integral TJ protein, claudin-1, over a time course similar to the reciprocal loss of the gap junction protein Cx43. Furthermore, this change in expression of junctional proteins is associated with morphological changes in the appositional astrocyte membranes, such that the gap junctions present in control cultures are apparently replaced, after IL-1␤ treatment, by loose particle strands reminiscent of rudimentary TJs. Although structural features of gap and TJs and expression of several protein components of these junctions are known to be susceptible to environmental stimuli (Citi, 1993; Spray et al., 1999) , this is the first report of such an effect on claudin expression in CNS.
There is increasing evidence that both gap junctions and TJs are macromolecular assemblies consisting of integral membrane proteins and other proteins that bind to them. In the case of TJs, occludin, members of the claudin family, and junction adhesion molecule (JAM) appear to be the membrane-embedded proteins (Fanning et al., 1999) , with zonula occludens family members (ZO-1, -2, and -3), cingulin, p130, 7H6, and possibly symplekin and ZA-1TJ being cytosolic binding partners (for review, see Mitic and Anderson, 1998) . In the case of Cx43, binding by v-src and by ZO-1 have been demonstrated, suggesting that gap junctions may also form a macromolecular structure (Giepsman and Moolenar, 1998; Toyofuku et al., 1998; Loo et al., 1999) . In this regard, it is interesting to note that connexin and claudin multigene families share analogous structural and physical properties. They both exist as four transmembrane domain (tetraspan) proteins with intracellular amino and carboxyl termini, and both bind the second PDZ domain of the membrane-associated guanylate kinase protein ZO-1 within the cell (Giepmans and Moolenaar, 1998; Itoh et al., 1999) . Connexins are known to form hexamers surrounding a hydrophilic pore through which ions and small molecules pass from cell to cell; claudins have been proposed to form hexamers that may create paracellular pores for ion and molecular diffusion in the spaces between cells .
In our experiments, the patterns of expression of Cln-1 and Cx43 protein in control and IL-1␤-treated cultures showed minimal overlap, with Cx43 rapidly being replaced by Cln-1 after IL-1␤ treatment. The observation that the expression pattern of Cln-1 was reciprocal to that of Cx43 suggests that Cln-1 may substitute for Cx43 at the scaffolding complex localized to astrocyte cell membranes. Together with our findings that levels of ZO-1 do not change in IL-1␤-treated astrocytes, this suggests the interesting possibility that exposure to IL-1␤ may result in the replacement of one tetraspan hexamer composed of connexons with another tetraspan hexamer composed of claudins and/or occludin at the same location in the scaffold localized to astrocyte cell membranes.
The switch in expression from one type of junctional protein to another is expected to result in profound effects on intercellular communication and extracellular diffusion in the CNS under inflammatory conditions. Under normal conditions, astrocytes are highly coupled by gap junctions formed primarily of Cx43, allowing for passage of information directly between cells. However, under inflammatory conditions this pathway could also allow the passage of apoptotic signals leading to widespread cell death (Lin et al., 1998) . Thus, IL-1␤ induced loss of Cx43 could provide a protective mechanism by which apoptosis is minimized in the damaged CNS. Alternatively, the signaling domain associated with Cx43 in normal astrocytes may be damaging to the cell under pathological conditions.
Although astrocytes are not normally connected by TJs, our results indicate that they express the tight junction-associated proteins ZO-1, ZO-2, and occludin, but lack expression of Cln-1. The electron micrographs of astrocyte appositional membranes after Cln-1 induction by IL-1␤ treatment showed small regions of close membrane apposition, and in FF we observed short linear particle arrays in P face membrane, but we did not observe membrane fusions or the elaborate tight junctional strands reported in Cln-1 transfected fibroblasts (Furuse et al., 1998b) . The fact that induction of Cln-1 in IL-1␤-treated astrocytes did not form complete tight junctional strands suggests that some component of the tight junction strands may have been missing or nonfunctional in these cells. This possibility is further suggested by the decline in occludin expression after IL-1␤ treatment, which began to occur at about the same time that Cln-1 expression was induced. Because it has been suggested that the tight junction complex may contain occludin in addition to claudin, it is possible that the mature tight junctional strands require this or another integral membrane protein.
We speculate that the rudimentary tight junction strands detected in human astrocytes after IL-1␤ treatment may perform a function of paracellular sealing, thereby contributing to the reduced effective volume of the extracellular space and the increased tortuosity observed after inflammatory lesions (Nicholson and Sykova, 1998) . Alternatively, or in addition, the junctional assemblies seen in astrocytes after IL-1␤ treatment may represent specialized microdomains that constitute a signalsome with novel roles in intercellular or extracellular signaling or adhesion (Denker et al., 1996; Saha et al., 1998) .
We conclude that the junctional complexes in human astrocytes are dynamic structures that can be modified by environmental A, Western blot analysis of the expression of Cx43 and Cln-1 after treatment with IL-1␤. Whole-cell extracts of control or IL-1␤ (10 ng/ml)-treated astrocytes were probed for Cln-1, Cx43, occludin and ZO-1, -2, and -3. No signal for Cln-1 was detected in control cultures; in contrast, expression of a single 22 kDa band corresponding to Cln-1 was observed within 6 hr after addition of IL-1␤ to cultures, with expression reaching a plateau at 15 hr. Levels of occludin were high in untreated cells but declined commencing 15-30 hr after IL-1␤ treatment. Treatment with IL-1␤ had no effect on expression of either ZO-1 or ZO-2. B, Western blot analysis of membrane fractions in control and IL-1␤ (10 ng/ml at 16 and 24 hr)-treated cells probed for Cx43 and Cln-1. No signal for Cx43 was detected at 16 hr or 24 hr after addition of IL-1␤ to cultures. In contrast, strong Cln-1 expression was observed at both 16 and 24 hr after IL-1␤ treatment (bottom panel ). This signal for Cln-1 was enriched in the membrane fraction (mb) compared with whole-cell extract (wc). C, Concentration-dependent effects of IL-1␤ on Cx43 and Cln-1 expression as determined by Western blot analysis. Effects of IL-1␤ on Cln-1 and Cx43 expression was detected at a dose as low as 10 pg/ml and were significantly inhibited by cotreatment with the naturally occurring IL-1 receptor antagonist (IL-1Ra, 500 ng/ml). Analysis by RT-PCR of mRNA expression for Cln-1 in astrocytes exposed to IL-1␤ is shown in D. Total RNA from untreated (control labeled C) and IL-1␤-treated (16 hr) human astrocyte cultures was subjected to first-strand reverse transcription followed by PCR for human Cln-1 and ␤-actin as described in Materials and Methods (lanes labeled RT ). As a control, the procedure was also performed in the absence of reverse transcriptase (lanes labeled N ). No signal for Cln-1 was detected in untreated cultures (top panel ) although ␤-actin expression (bottom panel ) was readily detected. In contrast, in astrocyte cultures treated with 10 ng/ml IL-1␤ for 16 hr robust expression of a single 650 bp band was detected using primers specific for human Cln-1. stimuli, including exposure to inflammatory cytokines and that in pathological conditions of the human CNS, elevated IL-1␤ expression significantly alters glial connectivity. The combined action of IL-1␤ on Cx43 and Cln-1 would be expected to reduce intercellular coupling and to decrease bulk fluid movement in the extracellular space. Both actions could contribute to local confinement of inflammatory responses, thereby limiting spread to surrounding uninvolved tissue. . Astrocytes were identified by the presence of well preserved square particle arrays on their P-faces (A, C, bottom right insets). Extensive gap junctions were found between control cells by both FF (A, gap junction shown at higher magnification in top left inset) and TEM ( B). After IL-1␤ treatment no gap junctions were seen. Instead, FF images showed strands of 10 nm intramembranous particles reminiscent of rudimentary tight junctions (C, higher magnification in top left inset) and TEM revealed areas of close membrane apposition ( D). A lower power view of a membrane from an IL-1␤-treated cell is seen in E, demonstrating the large numbers of particle strands found on these cells. Scale bars: A and C insets, 0.05 m.
